Prescribing Information
This document is provided in Adobe Portable Document Format (PDF). You will need Adobe Acrobat Reader to view this document.
Download a free copy of the software here.
Please see full Prescribing Information for AzaSite®.
AzaSite® (azithromycin ophthalmic solution) 1% is indicated for the treatment of bacterial conjunctivitis (pinkeye) in adults and children 1 year of age and older. Recommended dosing for AzaSite® is 1 drop twice a day for 2 days, followed by 1 drop once a day for the next 5 days, for a total of 9 drops per infected eye.
Important Safety Information: For use as an eyedrop only. In clinical trials, the most common adverse event was eye irritation, which occurred in 1% to 2% of patients. Other adverse events (occurring in <1% of patients) were burning, stinging, and eye irritation upon instillation; skin irritation or rash; corneal erosion; dry eye; altered taste; nasal congestion; eye discharge; inflammation of the cornea; and sinus infection.
This web site is intended only for residents of the United States.
©2008 AZA-0272 May 2008 Inspire Pharmaceuticals, Inc. AzaSite and DuraSite are registered trademarks of InSite Vision, Inc. All rights reserved.
